Clinical Trial Update: A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment [Phase 2]

View source ↗

Summary

A Phase 2 safety and effectiveness study of TMC435 in chronic genotype 1 hepatitis C patients who failed prior standard treatment has completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-02-06